GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
924,929
Share change
+791,929
Total reported value
$4,874,845
Price per share
$5.27
Number of holders
12
Value change
+$4,174,845
Number of buys
11

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q1 2015

As of 31 Mar 2015, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 924,929 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, WOLVERINE ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Citadel Advisors LLC, BANK OF MONTREAL /CAN/, JANE STREET GROUP, LLC, KCG Holdings, Inc., MORGAN STANLEY, UBS Group AG, and Creative Planning. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.